Podcast thumbnail for Shared Experiences in Oncology & Rare Diseases

Shared Experiences in Oncology & Rare Diseases

Claim This Podcast

by myTomorrows

1 episodes
Updated Daily
Accepts GuestsHas Sponsors

Podcast Overview

Shared Experiences in Oncology & Rare Diseases is for everyone working in oncology and rare diseases, or simply interested in deepening their knowledge and enhancing professional and personal development. Topics like pre-approval access ethics, clinical trials, expanded access, maintaining a good work-life balance, practice tips and tricks as well as many more, are covered.

Language

🇺🇲

Publishing Since

5/19/2022

2 verified contact emails on file for Shared Experiences in Oncology & Rare Diseases

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Shared Experiences in Oncology & Rare Diseases with Dr.Shannon and Mel Mann

May 19, 2022

Shared Experiences in Oncology & Rare Diseases with Dr.Shannon and Mel Mann

<p>This episode features two guests who were trailblazers in the development of a landmark cancer drug. Gleevec (imatinib) was a breakthrough in cancer treatment because it helped establish a new group of drugs called targeted therapies. Join us to hear the experiences of Dr. James Shannon, former global head of pharma development at Novartis who helped bring Gleevec to market, and Mel Mann, an early participant in the Gleevec clinical trial who is now the world’s longest-living Gleevec patient.  </p>

1 total episodes available

Deep-dive analytics for Shared Experiences in Oncology & Rare Diseases

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Shared Experiences in Oncology & Rare Diseases?

Shared Experiences in Oncology & Rare Diseases is for everyone working in oncology and rare diseases, or simply interested in deepening their knowledge and enhancing professional and personal development. Topics like pre-approval access ethics, clinical trials, expanded access, maintaining a good work-life balance, practice tips and tricks as well as many more, are covered.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.